吴歆, 耿旭强, 徐沪济 . 多基因风险评分在复杂性状疾病中的应用进展[J]. 诊断学理论与实践, 2020 , 19(05) : 540 -543 . DOI: 10.16150/j.1671-2870.2020.05.019
| [1] | Mistry S, Harrison JR, Smith DJ, et al. The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: a systema-tic review[J]. J Affect Disord, 2018, 234:148-155. |
| [2] | Mega JL, Stitziel NO, Smith JG, et al. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials[J]. Lancet, 2015, 385(9984):2264-2271. |
| [3] | Tada H, Melander O, Louie JZ, et al. Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history[J]. Eur Heart J, 2016, 37(6):561-567. |
| [4] | Natarajan P, Young R, Stitziel NO, et al. Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting[J]. Circulation, 2017, 135(22):2091-2101. |
| [5] | Khera AV, Emdin CA, Drake I, et al. Genetic risk, adherence to a healthy lifestyle, and coronary disease[J]. N Engl J Med, 2016, 375(24):2349-2358. |
| [6] | Xu Z, Liu H, Sun C, et al. Association between a genetic risk score based on single nucleotide polymorphisms of coronary artery disease-related genes and left main coronary artery disease[J]. Biomed Res Int, 2018, 2018:8610368. |
| [7] | Khera AV, Chaffin M, Aragam KG, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations[J]. Nat Genet, 2018, 50(9):1219-1224. |
| [8] | 韩俊庆. 临床肿瘤学指南[M]. 山东科学技术出版社, 2016. |
| [9] | Markham MJ, Wachter K, Agarwal N, et al. Clinical Cancer Advances 2020: annual report on progress against cancer from the American Society of Clinical Oncology[J]. J Clin Oncol, 2020, 38(10):1081. |
| [10] | Dai J, Lv J, Zhu M, et al. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations[J]. Lancet Respir Med, 2019, 7(10):881-891. |
| [11] | van Veen EM, Brentnall AR, Byers H, et al. Use of single-nucleotide polymorphisms and mammographic density plus classic risk factors for breast cancer risk prediction[J]. JAMA Oncol, 2018, 4(4):476-482. |
| [12] | Läll K, Lepamets M, Palover M, et al. Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification[J]. BMC Cancer, 2019, 19(1):557. |
| [13] | Palmer JR. Polygenic risk scores for breast cancer risk prediction: lessons learned and future opportunities[J]. J Natl Cancer Inst, 2020, 112(6):555-556. |
| [14] | Wen W, Shu XO, Guo X, et al. Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry[J]. Breast Cancer Res, 2016, 18(1):124. |
| [15] | Wang Z, Liu Q, Wilson CL, et al. Polygenic determinants for subsequent breast cancer risk in survivors of childhood cancer: the St Jude Lifetime Cohort Study (SJLIFE)[J]. Clin Cancer Res, 2018, 24(24):6230-6235. |
| [16] | Lencz T, Knowles E, Davies G, et al. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium(COGENT)[J]. Mol Psychiatry, 2014, 19(2):168-174. |
| [17] | Hubbard L, Tansey KE, Rai D, et al. Evidence of common genetic overlap between schizophrenia and cognition[J]. Schizophr Bull, 2016, 42(3):832-842. |
| [18] | Córdova-Palomera A, Kaufmann T, Bettella F, et al. Effects of autozygosity and schizophrenia polygenic risk on cognitive and brain developmental trajectories[J]. Eur J Hum Genet, 2018, 26(7):1049-1059. |
| [19] | Mallet J, Le Strat Y, Dubertret C, et al. Polygenic risk scores shed light on the relationship between schizophrenia and cognitive functioning: review and meta-analysis[J]. J Clin Med, 2020, 9(2):341. |
| [20] | Hettige NC, Cole CB, Khalid S, et al. Polygenic risk score prediction of antipsychotic dosage in schizophrenia[J]. Schizophr Res, 2016, 170(2-3):265-270. |
| [21] | Jones HJ, Hubbard L, Mitchell RE, et al. Association of genetic risk for rheumatoid arthritis with cognitive and psychiatric phenotypes across childhood and adolescence[J]. JAMA Netw Open, 2019, 2(6):e196118. |
| [22] | Ge T, Chen CY, Ni Y, et al. Polygenic prediction via Bayesian regression and continuous shrinkage priors[J]. Nat Commun, 2019, 10(1):1776. |
| [23] | Khan MAB, Hashim MJ, King JK, et al. Epidemiology of type 2 diabetes-global burden of disease and forecasted trends[J]. J Epidemiol Glob Health, 2020, 10(1):107-111. |
| [24] | Oram RA, Patel K, Hill A, et al. A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults[J]. Diabetes Care, 2016, 39(3):337-344. |
| [25] | Padilla-Martínez F, Collin F, Kwasniewski M, et al. Systematic review of polygenic risk scores for type 1 and type 2 diabetes[J]. Int J Mol Sci, 2020, 21(5):1703. |
/
| 〈 |
|
〉 |
